Valentina Appierto - Publications

Circulating tumor DNA in early breast cancer: Evidence, challenges, next steps.

Journal: Cancer

Published: March 30, 2026

Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].

Journal: EClinicalMedicine

Published: February 09, 2026

HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy.

Journal: NPJ breast cancer

Published: August 07, 2025

Health-related quality of life and fear of recurrence after early breast cancer treatment: Results from a cross-sectional survey.

Journal: Breast (Edinburgh, Scotland)

Published: August 05, 2025

Acquired HER2 expression promotes secondary metastasis in breast cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 21, 2025

Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study.

Journal: Frontiers in oncology

Published: April 30, 2025

Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy.

Journal: ESMO open

Published: December 21, 2020

Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 31, 2019

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy.

Journal: Cancers

Published: September 10, 2019

Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.

Journal: International journal of molecular sciences

Published: September 06, 2019

Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 02, 2018

How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case.

Journal: Seminars in cancer biology

Published: March 08, 2017